iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California.
| Revenue (Most Recent Fiscal Year) | $591.84M |
| Net Income (Most Recent Fiscal Year) | $-113.29M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 8.57 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 58.05 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -13.94% |
| Net Margin (Trailing 12 Months) | -7.32% |
| Return on Equity (Trailing 12 Months) | -45.00% |
| Return on Assets (Trailing 12 Months) | -4.49% |
| Current Ratio (Most Recent Fiscal Quarter) | 5.02 |
| Quick Ratio (Most Recent Fiscal Quarter) | 4.88 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 6.25 |
| Inventory Turnover (Trailing 12 Months) | 12.85 |
| Book Value per Share (Most Recent Fiscal Quarter) | $2.90 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.06 |
| Earnings per Share (Most Recent Fiscal Year) | $-3.08 |
| Diluted Earnings per Share (Trailing 12 Months) | $-1.61 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 32.13M |
| Free Float | 31.77M |
| Market Capitalization | $6.02B |
| Average Volume (Last 20 Days) | 0.33M |
| Beta (Past 60 Months) | 1.15 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 1.10% |
| Percentage Held By Institutions (Latest 13F Reports) | -- |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |